Elekta is committed to the development of cancer care. The company offers ongoing professional education awards and also encourages the adoption of standards to support the interoperability of multi-component systems. Learn more about our current programs summarized below.
ELEKTA可以通过包括提供研究资金,信息,访问研究硬件和/或软件的机制来支持调查员启动的研发协议项目,并访问其他ELEKTA资源。在交换中,Elekta预计以信息的形式受益,获得知识产权和研究结果,您的工作产品是您的工作产品。
Elekta has a long and rich tradition of supporting investigator initiated research that leads to advances in technology and clinical care. We depend on close collaborative relationships with investigators who are themselves leaders in their respective fields. These relationships and the results of our joint research efforts are among the keys to our success and leadership in our industry.
为了保持最高标准,我们制定了通过研究申请指导申请人的过程。该过程旨在导致互利的明确定义和高质量的研究计划。
Elekta的研究合作计划根据国际和美国联邦法规,管理医疗保健制造商提供的研究资金到医疗保健提供者。该计划符合Elekta Code of Conduct那医学影像和技术联盟(MITA)与医疗保健专业人士的互动界规规范,这制药商的合规计划指导从美国检查员办公室,美国联邦和美国联邦State Sunshine Reporting of Payments to Physicians。
Elekta可以通过包括:
您的工作将以信息形式,获取知识产权,研究结果等的elekta。
要申请研究资助,请填写申请表。要申请申请表,请发送电子邮件给您的请求scientific.research@elekta.com.。
This application has been adapted from U.S. National Institution of Health applications that are likely familiar to you. Applications should be focused, achievable and not overly ambitious. Please note that Elekta places a high value on having clearly defined goals and tasks, meeting specific milestones and providing associated deliverables. It should be made clear how these goals would be met and the tasks achieved. Please also limit your requests to that which would be required to complete the project.
The Elekta Research Grant Program is intended to support clinical and technological research activities that will advance knowledge and promote innovation. Research proposals shall be expected to demonstrate strong potential for clinical innovation, technological innovation or commercialization, relating to advancements in Elekta products and clinical solutions including Stereotactic Body Radiotherapy (SBRT).
Elekta’s research committee meets on a regular basis to review grant applications. We make our best effort to respond to you within 8-12 weeks of receipt of a completed application. If approved, we will work with you to develop a formal Research Agreement between Elekta and your Institution. The project only begins after the Research Agreement has been executed. No commitments should be made by the researcher in anticipation of this event.
为了优化直接研究贡献与研究的平衡,Elekta建立了一项公司政策,以支持最高资金水平,以实现25%的间接费用。这是一致的,在某些情况下,超过行业范围的资金水平以及基本上没有基于行业的基本上更大的研究支持计划的间接融资水平。
获取更多资讯,请联系:scientific.research@elekta.com.。
Elekta特别强调研究进展使用基于线性加速器的立体定向体放射治疗(SRT)和立体定向放射治疗(SRT)。强烈鼓励与使用线性加速器的SBRT相关的应用程序,并将优先考虑。
Elekta特别强调研究进展使用基于线性加速器的立体定向体放射治疗(SRT)和立体定向放射治疗(SRT)。强烈鼓励与使用线性加速器的SBRT相关的应用程序,并将优先考虑。
在过去的二十年中,立体定位体放射治疗的发展已经在显着发展。如今,SBRT在许多解剖部位肿瘤治疗常用。坚定的信念,即该技术具有改善成果的重要潜力,降低成本部分是推动这些努力。然而,技术和结果成果差异很大,仍有很多学习。
Consequently, Elekta is promoting efforts to advance the understanding of SBRT, particularly as it relates to its delivery using linear accelerator technology. A substantial proportion of our near-term research and development efforts will center on SBRT, and we invite our research partners to participate in these activities. Our granting mechanism is aimed at facilitating these efforts, and we encourage applications directed at these goals.
请参阅上面关于研究拨款和遵守国际和美国法规的一般信息的“研究授权”部分。您还将找到有关授予评估流程和ELEKTA政策的信息,以基于间接成本。
For further information or to request a grant application form, please email your request toscientific.research@elekta.com.。
ELEKTA的OpenRT认证计划建立了合规性,验证,部署和支持标准,以支持多组分系统的互操作性,并提高护理质量。
在Elekta,我们认为,标准合规和系统范围的功能是开发综合工具以提高整体过程效率的重要方面。ELEKTA的OpenRT认证计划建立了合规性,验证,部署和支持标准,以支持多组分系统的互操作性,并提高护理质量。通过OpenRT认证,客户可以购买治疗计划系统和EMR / V&R系统,而无需担心该系统将共同努力。
该程序可确保治疗计划系统,Elekta电子医疗记录(EMR)和线性加速器之间的连接,要求供应商转移有效管理治疗计划,设置和交付所需的所有数据。
通过OpenRT认证,在单个电话中提供技术支持。客户可以联系Elekta或其治疗计划供应商来解决出现的任何问题。
Elekta would like to acknowledgeNOMOSand飞利浦in their efforts to join us in establishing a program to ensure interoperability across multiple systems.
Please contact the program administrator,莱昂Tomczyk.那for additional information.
ELEKTA软件肿瘤学数据联盟(ODA)的使命是通过分析聚集肿瘤数据来改善患者癌症护理。bob体育网赌
The goal of the Oncology Data Alliance (ODA) is to improve patient cancer care through the analysis of aggregate oncology data. This data alliance will be unique in that:
一如既往,ELEKTA将适用并设定质量数据标准,并将纳入当前客户的反馈,使其成为肿瘤治疗中心的独特和有价值的评估和研究工具。基准报告可以帮助我们目前的客户最大限度地提高对ELEKTA软件的投资。通过专注于官方发展援助的团队,将有一个专门的Elekta员工,可以帮助各个客户网站以及整个数据库的官方发展援助的质量保证和数据质量。这些基准报告将允许参与设施:
每个参与者都进入了两年的可再生术语,并被要求完成最低的数据集要求,以保持高标准的质量。此外,参与设施将:
For more program information, contactDave Eggert
Elekta Software’s Registrar of the Year program honors outstanding Elekta Software cancer registrars who have made valuable contributions to the success of the registry and have expanded their contributions to the broader facility and community.
Elekta sponsors this award which is presented annually at the AANS meeting. Started in 2009, the award is for the best paper on stereotactic radiosurgery as related to brain tumors.
Each year Elekta sponsors an award for the best paper on stereotactic radiosurgery related to brain tumors amongst the Tumor Section members of AANS and CNS. Winners are presented at the AANS Annual Meeting.
Elekta Software registry customers regularly contribute data to Elekta Software’s National Oncology DataBase™ (NODB) through quality-checked submissions directly from their registry software. In return, Elekta Software provides primary site-specific aggregate data reports to contributors via the Internet. Elekta Software’s registry customers can use this information to generate annual reports, internal comparative reviews, and much more.
常常,Elekta被问及在专业文学中,专业会议海报或口腔演示文稿中使用我们的产品的正确方法。由于Elekta作为一个有机的实体和通过收购领先的行业公司及其产品,因此对适当的引用语言有相当困惑。
为了展示我们对交付Linear Accelerator用户的世界级立体定向解决管解决方案的承诺,Elekta介绍了一个旨在支持我们的协作和研究合作伙伴的计划。